8-Hydroxyeicosapentaenoic Acid Decreases Plasma and Hepatic Triglycerides via Activation of Peroxisome Proliferator-Activated Receptor Alpha in High-Fat Diet-Induced Obese Mice

Abstract EN

PPARs regulate the expression of genes involved in lipid homeostasis.

PPARs serve as molecular sensors of fatty acids, and their activation can act against obesity and metabolic syndromes.

8-Hydroxyeicosapentaenoic acid (8-HEPE) acts as a PPAR ligand and has higher activity than EPA.

However, to date, the PPAR ligand activity of 8-HEPE has only been demonstrated in vitro.

Here, we investigated its ligand activity in vivo by examining the effect of 8-HEPE treatment on high fat diet-induced obesity in mice.

After the 4-week treatment period, the levels of plasma and hepatic triglycerides in the 8-HEPE-fed mice were significantly lower than those in the HFD-fed mice.

The expression of genes regulated by PPARα was significantly increased in 8-HEPE-fed mice compared to those that received only HFD.

Additionally, the level of hepatic palmitic acid in 8-HEPE-fed mice was significantly lower than in HFD-fed mice.

These results suggested that intake of 8-HEPE induced PPARα activation and increased catabolism of lipids in the liver.

We found no significant differences between EPA-fed mice and HFD-fed mice.

We demonstrated that 8-HEPE has a larger positive effect on metabolic syndrome than EPA and that 8-HEPE acts by inducing PPARα activation in the liver.